Ensho Therapeutics raises $7.3M in its latest SEC filing
Ensho Therapeutics
- Raised in SEC filings
- $35.2M
- Filings
- 5
- Latest est. round
- Series A
- Incorporated
- 2024
- Industry
- Biotechnology
- Based in
- NJ
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-10-02 | $7.3M | Series A |
| 2026-01-20 | $0K | Series A |
| 2025-06-12 | $22.5M | Series A |
| 2024-10-24 | $5M | Seed |
| 2024-07-19 | $400K | Pre-seed/Seed |
Named in the latest filing
- Danielle Fry
- Arash Rassoulpour
- Carlos Solorzano
- Eric Pham
- Gerhard Hagn
- Neena Bitritto-Garg
- Tariq Kassum
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR